{"product_id":"the-university-of-texas-md-anderson-cancer-center-a","title":"The University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2023","description":"\u003ch3\u003eThe University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2023\u003c\/h3\u003e\n\u003cstrong\u003e Include: 75 videos + 38 pdfs, size: 39.1 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: hematologists, oncologists, primary care physician\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003eDate \u0026amp; Location Monday, September 25, 2023, 7:00 AM – Saturday, September 30, 2023, 5:10 PM, MD Anderson – Virtual\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Colon and Rectal Surgery, Gynecologic Oncology, Hematology, Medical Oncology, Neurological Surgery, Obstetrics and Gynecology, Thoracic Surgery, Urology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Genetic Counselor, Nurse – APRN, Pharmacist, Physician (MD or DO), Physician Associate, Student or Trainee\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003eThe University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2023\u003c\/div\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThe course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this activity, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eApply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.\u003c\/li\u003e\n\u003cli\u003eUtilize current standards of care for patients with cancer, blood disorders and malignancies.\u003c\/li\u003e\n\u003cli\u003eDemonstrate proficiency of knowledge in hematology and medical oncology.\u003c\/li\u003e\n\u003cli\u003eIncorporate recent advances in management of hematologic and oncologic patients.\u003c\/li\u003e\n\u003cli\u003eDefine molecular determinants of cancer risk and apply this knowledge in practice.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e31475_Brochure.Final-editedfe8.21.23.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Approach to Anemia.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Approach to Anemia.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Charles A. Koller, MD Lectureship Award – 2023 Recipient.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Disorders of Platelet Function.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Hemolytic Anemias.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Hemolytic Anemias.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Thrombocytopenias.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Bone Marrow Failure.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Bone Marrow Failure.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Hematopoietic Growth Factors.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Iron Deficiency and Hemochromatosis.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Iron Deficiency and Hemochromatosis.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Issues in Transfusion Medicine.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Leukopenia and Leukocytosis.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Antithrombotic \u0026amp; Antiplatelet Therapy.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Benign Hematology Q \u0026amp; A Session.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Benign Hematology Q \u0026amp; A Session.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Coagulation Factor Deficiencies, Including von Willebrands Disease and Hemophilias.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Hypercoagulable States.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Hypercoagulable States.pdf\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Normal Coagulation.mp4\u003c\/li\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Acute Lymphoblastic Leukemia.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Acute Lymphoblastic Leukemia.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Acute Myeloid Leukemia.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Acute Myeloid Leukemia.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Chronic Myeloid Leukemia.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Chronic Myeloid Leukemia.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Malignant Hematology Q \u0026amp; A Session.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Myelodysplastic Syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Leukemia MDS Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Aggressive Non-Hodgkin Lymphoma.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Classification of Lymphoma.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Hodgkin Lymphoma.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Hodgkin Lymphoma.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Indolent Non-Hodgkin Lymphoma.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Indolent Non-Hodgkin Lymphoma.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Multiple Myeloma and Other Plasma Cell Dyscrasias.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Myeloma Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Chronic Lymphocytic Leukemia and Hairy Cell Leukemia.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Chronic Lymphocytic Leukemia and Hairy Cell Leukemia.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Infectious Complications in Cancer Patients.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Myeloproliferative Neoplasms.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Myeloproliferative Neoplasms.pdf\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Q \u0026amp; A Panel Discussion 1.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Q \u0026amp; A Panel Discussion 2.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Stem Cell Transplant Supportive Care.mp4\u003c\/li\u003e\n\u003cli\u003eMALIGNANT HEMATOLOGY SESSION MPN CLL SCT Stem Cell Transplant Supportive Care.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Screening Local Management of Breast Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Solid Tumor Q \u0026amp; A – Session 1 Pharmacology Genetic Risk Factors Sarcoma Breast.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Solid Tumor Q \u0026amp; A – Session 1 Pharmacology Genetic Risk Factors Sarcoma Breast.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Special Issues in Breast Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Special Issues in Breast Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Systemic Treatment of Primary Breast Cancer Including HER2 Positive Breast Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Breast Cancer Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Colorectal Cancer Biology and Adjuvant Therapy.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Colorectal Cancer Biology and Adjuvant Therapy.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Gastroesophageal Cancers Hepatocellular Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Gastroesophageal Cancers Hepatocellular Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Metastatic Colorectal Cancer and Anal Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Metastatic Colorectal Cancer and Anal Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Pancreaticobiliary Cancers Unknown Primary.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Solid Tumor Q \u0026amp; A – Session 2 Lung Cancer Head and Neck Cancer Thyroid Cancer GI.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Melanoma.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Melanoma.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Prostate Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Prostate Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Renal Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Renal Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Testicular Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Urothelial Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Genitourinary Oncology Melanoma Urothelial Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer ASH ASCO Choosing Wisely Recommendations.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Early Stage and Locally Advanced Non-Small Cell Lung Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Early Stage and Locally Advanced Non-Small Cell Lung Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Head and Neck Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Head and Neck Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Metastatic Non-Small Cell Lung Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Metastatic Non-Small Cell Lung Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Small Cell Lung Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Small Cell Lung Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Thyroid Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Thyroid Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Cervical Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Cervical Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Neuro-Oncology.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Neuro-Oncology.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Ovarian Cancer and Unusual Ovarian Histologies.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Ovarian Cancer and Unusual Ovarian Histologies.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Solid Tumor Q \u0026amp; A – Session 3 Genitourinary Melanoma Neuro-Oncology Gyn Onc.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Uterine Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Neuro-Onc Gynecologic Oncology Uterine Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Genetic Risk Factors.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Genetic Risk Factors.pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Pharmacology I Chemotherapy.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Pharmacology II Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP).mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Pharmacology II Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP).pdf\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Pharmacology III Targeted Therapy (CD20, CD30, CD33, Proteasome, BCR-ABL KIT, FLT3, IDH1 2, CDK4 6, PI3K).mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Pharmacology IV Immunotherapy.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Sarcoma.mp4\u003c\/li\u003e\n\u003cli\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Sarcoma Sarcoma.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954445881442,"sku":"MED-AMB03697","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/The-University-of-Texas-MD-Anderson-Cancer-Center-A-Comprehensive-Board-Review-in-Hematology-and-Medical-Oncology-2023-scaled-1.jpg?v=1779376941","url":"https:\/\/meducourse.com\/products\/the-university-of-texas-md-anderson-cancer-center-a","provider":"Meducourse","version":"1.0","type":"link"}